Prima-Derm, S.L. is an international dermocosmetic company founded in 2008 by world-renowned chemist Dr. García Antón, recognized for the development of Acetyl Hexapeptide-8, the first anti-wrinkle peptide known for its botox-like effect.

With more than 15 years of expertise and rapid international expansion, Prima-Derm is deeply committed to science-driven skincare, combining pharmaceutical knowledge, innovation, and clinical evidence to deliver high-performance dermocosmetic solutions.

We pioneer the full development and control of every stage of our formulations, from research and analysis to production, guided by a deep understanding of the needs of patients, skin professionals, and international partners. Our in-house laboratories allow us to create proprietary active ingredients, including peptides, growth factors, and biotechnological extracts, as well as innovative delivery systems that ensure optimal bioavailability, high concentrations of actives, and proven efficacy.

Primaderm (formerly known as Singuladerm) is our flagship brand, specializing in advanced molecular and preventive skincare that bridges pharmaceutical science and dermocosmetics.
OneGen Lab complements our portfolio with a next-generation approach focused on innovation, technology, and future-oriented skin solutions.

Today, Prima-Derm operates globally, partnering with distributors and professionals worldwide to bring cutting-edge dermocosmetic science to international markets.

Prima-Derm, S.L.

Org chart

Teams

Offices